
Synecor
Synecor evolved from the confluence of several synergistic strategic relationships, initially in the field of interventional cardiology,.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | - | |
Total Funding | 000k |
Related Content
Synecor operates in the medical device industry, focusing on transforming innovative ideas into successful growth corporations. The company serves clients ranging from startups to established medical device firms, providing a unique 'New Technology Engine' that accelerates the development process and mitigates risks associated with launching new medical devices. Synecor's business model involves partnering with thought leaders in the medical device sector to develop technologies across various medical specialties. Revenue is generated through equity stakes in the companies it helps to launch and grow, as well as through successful exits and public offerings. The market Synecor operates in is highly specialized, targeting the medical technology and innovation sector. Key clients include emerging medical device companies seeking to navigate the complex landscape of regulatory approvals and market entry. Synecor's approach ensures that these companies can bring their innovations to market more efficiently and effectively, thereby driving growth and profitability.
Keywords: medical device innovation, growth corporations, New Technology Engine, risk mitigation, regulatory approvals, market entry, equity stakes, thought leaders, medical specialties, technology development.
Tech stack
Investments by Synecor
Edit